ArticleAdvances in virology2026
Frequency and Demographic Patterns of SARS-CoV-2 and Influenza Virus Infections in Khuzestan: A Retrospective Observational Study (2021-2023).
Article in Advances in virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe the frequency and demographic characteristics of SARS-CoV-2 and influenza infections, as well as their co-occurrence, among patients in Khuzestan province. Methods: This retrospective laboratory-based study was conducted at the Reference Laboratory of Ahvaz Jundishapur University of Medical Sciences. Between March 2021 and November 2023, respiratory swab samples from patients with suspected Coronavirus disease 2019 (COVID-19) or influenza referred from 64 affiliated healthcare institutions (23 health centers and 41 hospitals) were tested for SARS-CoV-2 and influenza A/B using RT-qPCR. Demographic and laboratory data were analyzed using chi-square and simple logistic regression, and the results were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Results: A total of 148,079 respiratory specimens were analyzed between 2021 and 2023. Among them, 41.2% tested positive for SARS-CoV-2 in 2021, 14.9% in 2022, and 4.5% in 2023, showing a marked decline in COVID-19 positivity over time. In contrast, influenza positivity progressively increased from 13.3% in 2021 to 15.5% in 2022 and 20.8% in 2023, coinciding with broader testing coverage. Females consistently showed higher infection rates for both viruses. The most affected age groups for COVID-19 shifted from 40 to 50 years in 2021 to 20-30 years in 2022 and ≥ 70 years in 2023, while influenza was more frequent among individuals under 20 years in 2023. Coinfection with SARS-CoV-2 and influenza was uncommon, detected in only 0.6% of the patients in 2023, predominantly involving the H1N1 subtype. Conclusion: The present study demonstrates a declining trend of SARS-CoV-2 infection alongside a progressive rise in influenza cases in southwest Iran from 2021 to 2023. The findings highlight age- and sex-related variations in infection patterns and underscore the value of continuous dual surveillance for both viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.